Skip to main content
SpringerLink
Log in

Blutbasierte Biomarker der Alzheimer-Krankheit

Tau-Proteinwerte im Blut als valider Marker der frühen Alzheimer-Erkrankung

  • journal club
  • Published:
InFo Neurologie & Psychiatrie Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Referenzen

  1. Schindler SE et al. Neurology. 2019 Aug 1. pii: 10.1212/WNL.0000000000008081. doi: https://doi.org/10.1212/WNL.0000000000008081. PMID:31371569

  2. Nakamura A et al. Nature 2018; 554: 249–54

    Article  CAS  Google Scholar 

  3. Palmqvist S et al. JAMA Neurol 2019; doi: https://doi.org/10.1001/jamaneurol.2019.1632

    Article  Google Scholar 

Literatur

  • Pase MP, Beiser AS, Himali JJ et al. Assessment of plasma total tau level as a predictive biomarker for dementia and related endophenotypes. JAMA Neurol 2019; 76: 598–606

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinik für Neurologie mit Institut für Translationale Neurologie, Universitätsklinikum Münster, Münster, Deutschland

    Thomas Duning (Leiter der Gedächtnisambulanz)

Authors
  1. Thomas Duning
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Thomas Duning.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Duning, T. Tau-Proteinwerte im Blut als valider Marker der frühen Alzheimer-Erkrankung. InFo Neurologie 21, 24–26 (2019). https://doi.org/10.1007/s15005-019-0209-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15005-019-0209-9

Search

Navigation